Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Larisa V. Gubareva"'
Autor:
Alissa O’Halloran, Krista Kniss, Carrie Reed, Rebecca Garten, Vivien G. Dugan, Melissa A Rolfes, David E. Wentworth, Shikha Garg, Anwar Isa Abd Elal, Xiyan Xu, Natalie Kramer, Alicia P Budd, Daniel B. Jernigan, Erin Burns, Noreen Alabi, Lenee Blanton, John Barnes, Calli Taylor, Larisa V. Gubareva, Charisse N Cummings, Alicia M. Fry, Lynnette Brammer, Wendy Sessions, Jacqueline M. Katz
Publikováno v:
Morbidity and Mortality Weekly Report
CDC collects, compiles, and analyzes data on influenza activity and viruses in the United States. During September 30, 2018-February 2, 2019,* influenza activity† in the United States was low during October and November, increased in late December,
Autor:
Krista Kniss, Lynnette Brammer, Xiyan Xu, Melissa A Rolfes, Larisa V. Gubareva, Alicia P Budd, Lenee Blanton, Sankan Nyanseor, James Stevens, John Barnes, Charisse N Cummings, Alissa O’Halloran, Alicia M. Fry, Anwar Isa Abd Elal, Erin Burns, Noreen Alabi, Matthew Biggerstaff, Wendy Sessions, Rebecca Kondor, David E. Wentworth, Shikha Garg, Daniel B. Jernigan, Vivien G. Dugan
Publikováno v:
Morbidity and Mortality Weekly Report
Influenza activity* in the United States during the 2018-19 season (September 30, 2018-May 18, 2019) was of moderate severity (1). Nationally, influenza-like illness (ILI)† activity began increasing in November, peaked during mid-February, and retu
Autor:
Margaret, Okomo-Adhiambo, Alicia M, Fry, Su, Su, Ha T, Nguyen, Anwar Abd, Elal, Elizabeth, Negron, Julie, Hand, Rebecca J, Garten, John, Barnes, Xu, Xiyan, Julie M, Villanueva, Larisa V, Gubareva, Reginald, McClinton
Publikováno v:
Emerging Infectious Diseases, Vol 21, Iss 1, Pp 136-141 (2015)
Emerging Infectious Diseases
Emerging Infectious Diseases
We report characteristics of oseltamivir-resistant influenza A(H1N1)pdm09 viruses and patients infected with these viruses in the United States. During 2013–14, fifty-nine (1.2%) of 4,968 analyzed US influenza A(H1N1)pdm09 viruses had the H275Y ose
Autor:
Daniel B. Jernigan, Lynnette Brammer, Mei Shang, Lisa A. Grohskopf, Natalie Kramer, Stacy L. Davlin, Anwar Isa Abd Elal, Brendan Flannery, Erin Burns, David E. Wentworth, Shikha Garg, Stephen Barnes, Sonja J. Olsen, Larisa V. Gubareva, Noreen Alabi, Desiree Mustaquim, Alicia P Budd, Joseph S. Bresee, Xiyan Xu, Rebecca Garten, John R. Barnes, Charisse N Cummings, Alicia M. Fry, Lenee Blanton, Jacqueline M. Katz, Wendy Sessions, Krista Kniss
Publikováno v:
MMWR. Morbidity and mortality weekly report. 65(50-51)
This report summarizes U.S. influenza activity* during October 2-December 17, 2016.† Influenza activity in the United States remained low in October and has been slowly increasing since November. Influenza A viruses were identified most frequently,
Autor:
Desiree Mustaquim, Rebecca Garten, Natalie Kramer, Lenee Blanton, Lisa A. Grohskopf, Daniel B. Jernigan, Erin Burns, Joseph S. Bresee, Alicia M Fry, Krista Kniss, Jessica Cohen, Jacqueline M. Katz, Lynnette Brammer, Anwar Isa Abd Elal, Xiyan Xu, Brendan Flannery, John R. Barnes, Wendy Sessions, Teresa R. Wallis, Charisse N Cummings, Stacy L. Davlin, Larisa V. Gubareva, David E. Wentworth, Shikha Garg, Sophie Smith
Publikováno v:
Scopus-Elsevier
During the 2015-16 influenza season (October 4, 2015-May 21, 2016) in the United States, influenza activity* was lower and peaked later compared with the previous three seasons (2012-13, 2013-14, and 2014-15). Activity remained low from October 2015
Autor:
Larisa V. Gubareva, Katrina Sleeman, Zack Moore, Alicia M. Fry, Susan Kilpatrick, Shikha Garg, Tiffany G. Sheu
Publikováno v:
Emerging Infectious Diseases, Vol 17, Iss 11, Pp 2043-2046 (2011)
Emerging Infectious Diseases
Emerging Infectious Diseases
Oseltamivir is 1 of 2 antiviral medications available for the treatment of influenza B virus infections. We describe and characterize a cluster of influenza B viruses circulating in North Carolina with a mutation in the neuraminidase active site that
Autor:
Chao Yang Pan, Saumil Doshi, Laurie Kamimoto, Christine L. Waters, Larisa V. Gubareva, Margaret Okomo-Adhiambo, Kirsten St. George, Samuel B. Graitcer, Alexander Klimov, Zack Moore, Alicia M. Fry, Steven A. Marshall, Meredith Vandermeer, Jennifer Laplante, Janice K. Louie, Katrina Sleeman
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 17, Iss 2, Pp 255-257 (2011)
Emerging Infectious Diseases, Vol 17, Iss 2, Pp 255-257 (2011)
During April 2009–June 2010, thirty-seven (0.5%) of 6,740 pandemic (H1N1) 2009 viruses submitted to a US surveillance system were oseltamivir resistant. Most patients with oseltamivir-resistant infections were severely immunocompromised (76%) and h